Treatment of Obesity-Related Complications with Novel Classes of Naturally Occurring PPAR Agonists

廖美齡、施承典（2003）。Recent Advances in Pharmacotherapy of Obesity。台灣醫學，7(2)，263-271。https://doi.org/10.6320/FJM.2003.7(2).17
李宗澔（2020）。The association of obesity indicators with the genetic predisposition to diabetes, hypertension, and hyperlipidemia〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU202002854
李弘元（2004）。The Association of Vascular Adhesion Protein-1 and Obesity〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2004.01101
Gerhard, G. S., Benotti, P., Wood, G. C., Chu, X., Argyropoulos, G., Petrick, A., Strodel, W. E., Gabrielsen, J. D., Ibele, A., Still, C. D., Kingsley, C., & DiStefano, J. (2014). Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity. Journal of Obesity, (2014), s1-8. https://doi.org/10.1155/2014/368210
Hirai, S., Takahashi, N., Goto, T., Lin, S., Uemura, T., Yu, R., & Kawada, T. (2010). Functional Food Targeting the Regulation of Obesity-Induced Inflammatory Responses and Pathologies. Mediators of Inflammation, 2010(), 382-389. https://doi.org/10.1155/2010/367838